Observational studyCirculation2018

Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.

Konstantinos C Siontis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.